GlaxoSmithKline (GSK) Posts Improved Q4 EPS of 32.6p; Revs Ease
GlaxoSmithKline (NYSE: GSK) reported Q4 EPS of 32.6p ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
